PARIDIPRUBART
UNII 4LH8QAS0LR

Substance Identification & Data

This profile provides standardized clinical and technical data for Paridiprubart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4LH8QAS0LR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2641646-59-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4LH8QAS0LR

CAS Registry Number

2641646-59-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PARIDIPRUBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C182630

National Cancer Institute reference terminology for clinical and research data.

INN ID

12233

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-93

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Paridiprubart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PARIDIPRUBART

Common Names & Synonyms

IMMUNOGLOBULIN G1 (326-SERINE,329-PHENYLALANINE,DE-448-LYSINE), ANTI-(HUMAN TOLL-LIKE RECEPTOR 4) (HUMAN-MUS MUSCULUS MONOCLONAL EB05 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL EB05 .KAPPA.-CHAIN, DIMER

NI-0101

PARIDIPRUBART [INN]

PARIDIPRUBART [USAN]